EI
CYTK icon

EAM Investors’s Cytokinetics CYTK Stock Holding History

EAM Investors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,625
Closed -$2.85M – 275
2024
Q1 		$2.85M Sell
40,625
-6,580
-14% -$509K 0.44% 124
2023
Q4 		$3.94M Buy
+47,205
New +$1.71M 0.7% 38
2022
Q4 		– Sell
-77,259
Closed -$3.74M – 282
2022
Q3 		$3.74M Buy
77,259
+6,457
+9% +$311K 0.81% 12
2022
Q2 		$2.78M Buy
70,802
+4,547
+7% +$183K 0.68% 25
2022
Q1 		$2.44M Sell
66,255
-41,743
-39% -$1.48M 0.45% 73
2021
Q4 		$4.92M Sell
107,998
-2,576
-2% -$99.4K 0.81% 10
2021
Q3 		$3.95M Buy
+110,574
New +$3.26M 0.67% 24
2020
Q4 		– Sell
-31,647
Closed -$685K – 315
2020
Q3 		$685K Sell
31,647
-93,531
-75% -$2.19M 0.16% 250
2020
Q2 		$2.95M Buy
+125,178
New +$2.35M 0.65% 28
2016
Q2 		– Sell
-306,003
Closed -$2.16M – 315
2016
Q1 		$2.16M Sell
306,003
-113,469
-27% -$829K 0.34% 145
2015
Q4 		$4.39M Buy
+419,472
New +$4.11M 0.57% 25
2013
Q3 		– Sell
-202,465
Closed -$2.34M – 328
2013
Q2 		$2.34M Buy
+202,465
New +$1.59M 0.51% 39

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

EAM Investors's CYTK Position: Q2 2024 in Review

EAM Investors sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 40,625 shares — an estimated $2.85M sold.

EAM Investors first reported a position in CYTK in Q2 2013 and held it in 12 quarters. The position peaked at $4.92M in Q4 2021. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • EAM Investors reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • EAM Investors sold 40,625 Cytokinetics shares in Q2 2024, an estimated $2.85M.
  • EAM Investors first reported a position in Cytokinetics in Q2 2013 and held it in 12 quarters.
  • EAM Investors's Cytokinetics position peaked at $4.92M in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.